Bildkälla: Stockfoto

Bioservo: Redeye resumes coverage following rights issue - Redeye

Redeye resumes its coverage of Bioservo Technologies following the completion of the rights issue, adding SEK 37m before transaction cost.

Redeye resumes its coverage of Bioservo Technologies following the completion of the rights issue, adding SEK 37m before transaction cost.
Börsvärldens nyhetsbrev
ANNONSER